Multicenter, Randomised, Double-blind Phase III Trial to Investigate the Efficacy and Safety of BIBF 1120 in Combination With Carboplatin and Paclitaxel Compared to Placebo Plus Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
The trial will be performed to evaluate if BIBF 1120 in combination with paclitaxel and carboplatin is more effective than placebo in combination with paclitaxel and carboplatin in first-line treatment of patients with advanced ovarian cancer. Safety information about BIBF1120/paclitaxel/carboplatin will be obtained.
(Ovarialkarzinom, Eierstockkrebs- ovarian cancer, Eierstockkarzinom, Genitalmalignom, Eileiterkrebs, Eileiterkrebserkrankung, Peritonealkarzinom, Peritonealkarzinose, Gynäkologie)
